Brenda Libby Coleman

Array ( [id] => 5107721 [patent_doc_number] => 20070066599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'New compounds' [patent_app_type] => utility [patent_app_number] => 11/509989 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34180 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066599.pdf [firstpage_image] =>[orig_patent_app_number] => 11509989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107720 [patent_doc_number] => 20070066598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 11/509914 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34247 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066598.pdf [firstpage_image] =>[orig_patent_app_number] => 11509914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127203 [patent_doc_number] => 08575152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Non-steroidal compounds useful as glucocorticoid receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/065241 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14972 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12065241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149556 [patent_doc_number] => 20070049616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Organic compounds' [patent_app_type] => utility [patent_app_number] => 11/508445 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52735 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049616.pdf [firstpage_image] =>[orig_patent_app_number] => 11508445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057643 [patent_doc_number] => 20070060565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors' [patent_app_type] => utility [patent_app_number] => 11/507731 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28296 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060565.pdf [firstpage_image] =>[orig_patent_app_number] => 11507731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4460890 [patent_doc_number] => 07879840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Agents for preventing and treating disorders involving modulation of the RyR receptors' [patent_app_type] => utility [patent_app_number] => 11/506285 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 43 [patent_no_of_words] => 49703 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879840.pdf [firstpage_image] =>[orig_patent_app_number] => 11506285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8103947 [patent_doc_number] => 08153622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => '8-substituted benzoazepines as toll-like receptor modulators' [patent_app_type] => utility [patent_app_number] => 12/064193 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 15447 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153622.pdf [firstpage_image] =>[orig_patent_app_number] => 12064193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107724 [patent_doc_number] => 20070066602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Process for Making Olanzapine Form I' [patent_app_type] => utility [patent_app_number] => 11/465428 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4349 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066602.pdf [firstpage_image] =>[orig_patent_app_number] => 11465428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949924 [patent_doc_number] => 20080306050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Aminodiazepines as Toll-Like Receptor Modulators' [patent_app_type] => utility [patent_app_number] => 12/064196 [patent_app_country] => US [patent_app_date] => 2006-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14785 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306050.pdf [firstpage_image] =>[orig_patent_app_number] => 12064196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107716 [patent_doc_number] => 20070066594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Crystalline forms fenoldopam mesylate' [patent_app_type] => utility [patent_app_number] => 11/505229 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8594 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066594.pdf [firstpage_image] =>[orig_patent_app_number] => 11505229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5603012 [patent_doc_number] => 20060293357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Intermediates for synthesis of vinblastine, process for preparation of the intermediates and process for synthesis of vinblastines' [patent_app_type] => utility [patent_app_number] => 11/464560 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13048 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293357.pdf [firstpage_image] =>[orig_patent_app_number] => 11464560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5155094 [patent_doc_number] => 20070037977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Substituted-1, 3-oxathiolanes and substituted-1, 3-dioxolanes with antiviral properties' [patent_app_type] => utility [patent_app_number] => 11/502602 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20341 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037977.pdf [firstpage_image] =>[orig_patent_app_number] => 11502602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670452 [patent_doc_number] => 20080045512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Benzoate salt of 4-(5-methyl-oxazolo[4,5-b]-pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane' [patent_app_type] => utility [patent_app_number] => 11/501289 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9171 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045512.pdf [firstpage_image] =>[orig_patent_app_number] => 11501289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436243 [patent_doc_number] => 20090170830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer\'s Disease' [patent_app_type] => utility [patent_app_number] => 11/989919 [patent_app_country] => US [patent_app_date] => 2006-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8971 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170830.pdf [firstpage_image] =>[orig_patent_app_number] => 11989919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586026 [patent_doc_number] => 20090105228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Heterocyclic benzodiazepine cgrp receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/988986 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24714 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105228.pdf [firstpage_image] =>[orig_patent_app_number] => 11988986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162912 [patent_doc_number] => 07671196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Diazepinoquinolines, synthesis thereof, and intermediates thereto' [patent_app_type] => utility [patent_app_number] => 11/491590 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7978 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671196.pdf [firstpage_image] =>[orig_patent_app_number] => 11491590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149520 [patent_doc_number] => 20070049580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'ANXIOLYTIC AGENTS WITH REDUCED SEDATIVE AND ATAXIC EFFECTS' [patent_app_type] => utility [patent_app_number] => 11/458855 [patent_app_country] => US [patent_app_date] => 2006-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26957 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049580.pdf [firstpage_image] =>[orig_patent_app_number] => 11458855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5243110 [patent_doc_number] => 20070021605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'PROCESS AND COMPOSITION FOR MAKING OLANZAPINE FORM I' [patent_app_type] => utility [patent_app_number] => 11/458513 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3622 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021605.pdf [firstpage_image] =>[orig_patent_app_number] => 11458513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860351 [patent_doc_number] => 20080269201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Azepane- or Azocane-Substituted Pyrazoline Derivatives, Their Preparation and Use as Medicaments' [patent_app_type] => utility [patent_app_number] => 11/995750 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16758 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269201.pdf [firstpage_image] =>[orig_patent_app_number] => 11995750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728051 [patent_doc_number] => 20080207595 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2008-08-28 [patent_title] => 'Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin' [patent_app_type] => utility [patent_app_number] => 11/487884 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 217049 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0207/20080207595.pdf [firstpage_image] =>[orig_patent_app_number] => 11487884 [rel_patent_id] =>[rel_patent_doc_number] =>)